Laboratory Products

  • Slides that Run 2 Diagnostics Tests Simultaneously Awarded CE Mark

Slides that Run 2 Diagnostics Tests Simultaneously Awarded CE Mark

May 10 2019 Read 526 Times

Ortho Clinical Diagnostics’ new VITROS® XT MicroSlide system has been awarded CE Mark certification. This groundbreaking, multi-test technology allows labs to run two tests on one slide simultaneously, thereby simplifying workflow and improving productivity and turnaround time in the lab.  Currently, available test pairs include: triglycerides and cholesterol; urea and creatinine; glucose and calcium; bilirubin and alkaline phosphatase. 
VITROS XT MicroSlide is powered by the cutting-edge digital imaging optics technology, DIGITAL CHEMISTRY™, which extracts considerably more information from each test whilst requiring less patient sample. This is an important advantage for vulnerable patients or those with venous access issues. 
Labs achieve reliable high-quality results they can trust and increased productivity and efficiency by simultaneously performing two tests that are commonly ordered together from a single small blood sample. This improves lab productivity and turnaround time, while simplifying inventory management and optimising storage space.
"The Ortho VITROS XT MicroSlide is a great technological leap, with DIGITAL CHEMISTRY signifying a true revolution in the pursuit of consistently reliable and accurate clinical diagnoses," said Dr Jorge Aldunate Ortega, Clinical Laboratory Manager of RedSalud in Chile. "This technology reinforces Ortho as the trusted leader in the field of chemistry and immunodiagnostics."  
Ortho's VITROS XT MicroSlides, which include VITROS® XT UREA-CREA, TRIG-CHOL, GLU-Ca Slides and TBIL-ALKP, have received CE Mark signifying conformance to applicable European Union regulatory requirements. 
Additionally, Ortho recently announced CE Mark for its next-generation VITROS® High Sensitivity Troponin I assay, the latest addition to the company’s robust cardiology menu and a critical tool for clinicians who are seeking improved strategies to more rapidly and accurately identify patients suffering from a heart attack. Ortho’s VITROS XT MicroSlides and the VITROS High Sensitivity Troponin I assay are available commercially in all countries that accept CE Mark, including Chile and Australia.

Reader comments

Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.

Post a Comment

Digital Edition

Lab Asia April 2019

April 2019

In This Edition Articles - Mobile Affinity Sorbent Chromatography Of Proteins - Integration of MS and UV Data for Peak Tracking in HPLC Method Development - VMXm takes its First Users 'wher...

View all digital editions


ASMS Conference

Jun 02 2019 Atlanta, GA, USA

Drug Discovery Summit

Jun 10 2019 Berlin, Germany

HPLC 2019

Jun 16 2019 Milan, Italy

Chemspec Europe

Jun 26 2019 Basel, Switzerland

View all events